发明名称 LIPID BIOMARKERS OF HEALTHY AGEING
摘要 In one aspect there is provided a method for predicting a risk of unhealthy ageing in a subject, comprising: (a) determining a level of two or more lipid biomarkers in a sample from the subject, wherein the biomarkers are selected from two or more of the following groups: (i) a triacylglycerol (TAG) from TAG (46:5) to TAG (54:3); (ii) an ether phosphatidylcholine (PC-O) from PC-O(28:0) to PC-O(38:6); (iii) a sphingomyelin (SM) from SM (33:1) to SM(50:1); (iv) a phosphatidylcholine (PC) from PC (32:1) to PC (40:5); (v) a phosphatidylinositol (PI) from PI (36:1) to PI (38:3); (vi) a phosphatidylethanolamine (PE) from PE (36:2) to PE (38:4); and (b) comparing the levels of the biomarkers in the sample to reference values; wherein the levels of the biomarkers in the sample compared to the reference values are indicative of the risk of unhealthy ageing in the subject.
申请公布号 US2016245786(A1) 申请公布日期 2016.08.25
申请号 US201415028244 申请日期 2014.11.05
申请人 NESTEC S.A. 发明人 Collino Sebastiano;Montoliu Roura Ivan;Martin Françios-Pierre;Beguelin Fiona Camille;Rezzi Serge André Dominique
分类号 G01N33/487 主分类号 G01N33/487
代理机构 代理人
主权项 1. A method for predicting a risk of unhealthy ageing in a subject, comprising: (a) determining a level of two or more lipid biomarkers in a sample from the subject, wherein the biomarkers are selected from two or more of the following groups: (i) a triacylglycerol (TAG) from TAG(46:1) to TAG(54:6);(ii) an ether phosphatidylcholine (PC-O) from PC-O(28:0) to PC-O(38:6);(iii) a sphingomyelin (SM) from SM(33:1) to SM(50:4);(iv) a phosphatidylcholine (PC) from PC(32:1) to PC(40:5);(v) a phosphatidylinositol (PI) from PI(36:1) to PI(38:3);(vi) a phosphatidylethanolamine (PE) from PE(36:2) to PE(38:4); and (b) comparing the levels of the biomarkers in the sample to reference values; wherein the levels of the biomarkers in the sample compared to the reference values are indicative of the risk of unhealthy ageing in the subject.
地址 Vevey CH